Skip to main content
SpringerLink
Log in

Immunotherapy

Engineered T cells for all

  • Research Highlight
  • Published:

From Nature Reviews Cancer

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Qasim, W. et al. Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells. Sci. Transl Med. 9, eaaj2013 (2017)

    Article  Google Scholar 

Download references

Authors
  1. Gemma K. Alderton
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alderton, G. Engineered T cells for all. Nat Rev Cancer 17, 206–207 (2017). https://doi.org/10.1038/nrc.2017.19

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrc.2017.19

  • Springer Nature Limited

This article is cited by

Search

Navigation